DEPTOR is linked to a TORC1-p21 survival proliferation pathway in multiple myeloma cells

Yonghui Yang1, Carolyne Bardeleben1, Patrick Frost1

  • 1Department of Medicine, Hematology-Oncology, Greater Los Angeles VA Healthcare Center, Los Angeles, CA, USA ; UCLA School of Medicine, Greater Los Angeles VA Healthcare Center, Los Angeles, CA, USA.

Genes & Cancer
|January 9, 2015
PubMed

Insights

Gene silencing of DEPTOR, a multiple myeloma (MM) cell growth regulator, triggers cell death via the TORC1/p21 pathway. This mechanism involves p21 upregulation and is influenced by p21-targeting microRNAs.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Cell Biology

Background:

  • Multiple myeloma (MM) is a hematological malignancy characterized by uncontrolled plasma cell proliferation.
  • The mechanistic target of rapamycin (mTOR) pathway is a key regulator of cell growth and survival, and its inhibition is a therapeutic strategy in cancer.
  • DEPTOR (Dishevelled, Egl-10, and Pleckstrin homology domains-containing protein) is an endogenous inhibitor of mTOR signaling.

Purpose of the Study:

  • To elucidate the mechanism by which gene silencing of DEPTOR induces cytoreductive effects on multiple myeloma cells.
  • To investigate the role of the mTOR pathway, specifically TORC1 and AKT/SGK signaling, in DEPTOR knockdown-induced MM cell death.
  • To determine the involvement of p21, endoplasmic reticulum (ER) stress, and microRNAs (miRNAs) in the anti-MM effects of DEPTOR silencing.

Main Methods:

  • Gene silencing of DEPTOR using inducible short hairpin RNA (shRNA) in MM cell lines (e.g., 8226).
  • Assessment of mTOR pathway activation (TORC1, AKT/SGK), apoptosis, cell cycle arrest, senescence, and ER stress markers.
  • Evaluation of p21 expression, p53 dependence, and the role of p21 knockdown or overexpression of AKT activity.
  • In vivo studies using a murine xenograft model and analysis of p21-targeting miRNAs.

Main Results:

  • DEPTOR knockdown induced TORC1 activation, apoptosis, cell cycle arrest, and senescence in MM cells.
  • Cytotoxic effects were dependent on TORC1 activity but not AKT activity, and were independent of ER stress.
  • DEPTOR silencing led to p53-independent p21 upregulation, which was crucial for MM cell death.
  • DEPTOR knockdown in vivo resulted in anti-MM effects associated with p21 upregulation and decreased expression of p21-targeting miRNAs.

Conclusions:

  • DEPTOR gene silencing effectively inhibits multiple myeloma cell growth and survival through a TORC1/p21 signaling axis.
  • p21 induction, independent of p53 and ER stress, is a critical mediator of DEPTOR knockdown-induced cytotoxicity in MM.
  • p21-targeting miRNAs may play a regulatory role in the DEPTOR-mediated control of MM cell fate.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K